Lv1
90 积分 2025-04-17 加入
Immunogenicity and Immune Complex Disease in Preclinical Safety Studies
7天前
已完结
Hitching a Ride to Overcome Barriers: Nonclinical Safety Considerations for Bioconjugated Oligonucleotides
1个月前
已完结
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
2个月前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
4个月前
已完结
Combining VEGF and PD-1/PD-L1 inhibition in advanced hepatocellular carcinoma: clinical trials, real-world evidence, and future directions
5个月前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
5个月前
已完结
Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties
6个月前
已完结
Treatments for Alzheimer's disease emerge
9个月前
已完结
Risk of Chronic Rhinosinusitis with Nasal Polyps in Endotypes of Dermatophagoides pteronyssinus-Induced Rhinitis
11个月前
已完结
Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria
11个月前
已完结
皖公网安备34019202002308
